1970 MD, University of Zagreb, Zagreb, Yugoslavia
1971 Internship in Radiology, Hospital M. Stojanovic, Zagreb, Yugoslavia
1972 Residency in Radiology, Hospital M. Stojanovic, Zagreb, Yugoslavia
1974-1977 Residency in Radiology, St. Joseph Mercy Hospital, Pontiac Michigan
1977-1978 Fellowship in CT/US, Henry Ford Hospital, Detroit, Michigan
1992 D.S.M. (Ph.D), Karolinska Institute, Stockholm, Sweden

MRI
Ovarian cancer
Prostate cancer
Cervix cancer
Kidney cancer
CT

1978-1981 Henry Ford Hospital, Detroit, MI, Senior Staff, Diagnostic Radiology
1979-1981 University of Michigan, Ann Arbor, MI, Assistant Clinical Professor, Diagnostic Radiology,
1982-1983 University of California, San Francisco, Assistant Professor; 1983-1986 Associate Professor
1986-1999 Professor of Radiology, Urology, Radiation Oncology and Obstetrics, Gynecology and Reproductive Sciences
1999-present Memorial Sloan-Kettering Cancer Center, Chairman, Department of Radiology
1999-present Sloan-Kettering Institute for Cancer Research, Program of Molecular and Pharmacology Therapeutics
2000-present Weill Medical College of Cornell University, Professor of Radiology

Zakian KL, Sircar K, Hricak H, Shukla-Dave A*, Eberhardt S, Muruganandham M, Chen H, Kattan MW, Reuter V, Scardino P, Koutcher JA. Correlation of Proton MR Spectroscopic Imaging with Gleason Score Based on Step Section Pathology after Radical Prostatectomy. Radiology 2005; 234(3):804-14.

Hricak H, Gatsonis C, Chi DS, Amendola MA, Brandt K, Schwartz LH, Koelliker S, Siegelman ES, Brown JJ, McGhee RB Jr, Iyer R, Vitellas KM, Snyder B, Long HJ 3rd, Fiorica JV, Mitchell DG. Role of Imaging in Pretreatment Evaluation of Early Invasive Cervical Cancer: Results of the Intergroup Study American College of Radiology Imaging Network 6651- Gynecologic Oncology Group 183. J Clin Oncol 2005;23(36):9329-37

Amendola M, Hricak H, Mitchell DG, Chi DS, Snyder B, Gatsonis C, Long HJ, Fiorica JV. Utilization of diagnostic studies in the pretreatment evaluation of invasive cervical cancer in the United States: results of intergroup protocol ACRIN 6651/GOG 183. J Clin Oncol 2005 Oct; 23(30):7454-7459.

Mitchell DG, Synder B, Coakley F*, Reinhold C, Thomas G, Amendola M, Schwartz L, Woodward P, Pannu H, Hricak H. Early Invasive Cervical Cancer: Tumor Delineation by Magnetic Resonance Imaging, Computed Tomography, and Clinical Examination, Verified by Pathologic Results in the ACRIN 6651/GOG 183 Intergroup Study. Journal Clinical Oncology. 2006;24(36):5687-94.

Akin O*, Sala E, Moskowitz CS, Kuroiwa K, Ishill NM, Pucar D*, Scardino PT, Hricak H. Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR imaging. Radiology 2006 Jun; 239 (3): 784-92

Mitchell DG, Synder B, Coakley F*, Reinhold C, Thomas G, Amendola M, Schwartz L, Woodward P, Pannu H, Hricak H. Early Invasive Cervial Cancer: Tumor Delineation by Magnetic Resonance Imaging, Computed Tomography, and Clinical Examination, Verified by Pathologic Results in the ACRIN 6651/GOG 183 Intergroup Study. Journal Clincal Oncology. 2006 Dec;24(36):5687-94

Wang L*, Hricak H, Kattan MW, Chen HN, Kuroiwa K, Eisenberg HF, Scardino PT. Prediction of Seminal Vesicle Invasion in Prostate Cancer: Incremental Value of Adding Endorectal MR Imaging to the Kattan Nomogram. Radiology. 2007 Jan; 242(1):182-8

Shukla-Dave A*, Hricak H, Kattan MW, Pucar D*, Kuroiwa K, Chen HN, Spector J, Koutcher JA, Zakian KL, Scardino PT. The utility of magnetic resonance imaging and spectroscopy for predicting insignificant prostate cancer: an initial analysis. BJU Int. 2007 Apr;99(4):786-93.

Riedl CC*, Akhurst T, Larson S, Stanziale SF, Tuorto S, Bhargava A, Hricak H, Klimstra D, Fong Y.18F-FDG PET Scanning Correlates with Tissue Markers of Poor Prognosis and Predicts Mortality for Patients After Liver Resection for Colorectal Metastases. J Nucl Med. 2007 May;48(5):771-775.

Pucar D*, Hricak H, Shukla-Dave A*, Kuroiwa K, Drobnjak M, Eastham J, Scardino PT, Zelefsky MJ. Clinically significant prostate cancer local recurrence after radiation therapy occurs at the site of primary tumor: magnetic resonance imaging and step-section pathology evidence. Int J Radiat Oncol Biol Phys. 2007 Sep 1;69(1):62-9.

Shukla-Dave A*, Hricak H, Moskowitz C, Ishill N, Akin O*, Kuroiwa K, Spector J, Kumar M, Reuter VE, Koutcher JA, Zakian KL. Detection of Prostate Cancer with MR Spectroscopic Imaging: An Expanded Paradigm Incorporating Polyamines. Radiology. 2007 Nov 245(2):499-506.

Brader P*, Riedl CC*, Woo Y, Ponomarev V*, Zanzonico P, Wen B, Cai S, Hricak H, Fong Y, Blasberf R, Serganova I. Imaging of hypozia-driven gene expression in an orthopic liver tumor model. Mol Cancer Ther. 2007 Nov;6(11):2900-8.

Hricak H, Gatsonis C, Coakley FV*, Snyder B, Reinhold C, Schwartz LH, Woodward PJ, Pannu HK, Amendola M, Michell DG. Early invasive cervical cancer: CT and MR imaging in preoperative evaluation - ACRIN/GOG comparative study of diagnostic performance and interobserver variability. Radiology. 2007 Nov;245(2):491-8.

Mazaheri Y*, Shukla-Dave A*, Hricak H, Fine SW, Zhang, J*, Inurrigarro G, Moskowitz CS, Ishill NM, Reuter VE, Touijer K, Zakian KL, Koutcher JA. Prostate cancer: identification with combined diffusion-weighted MR imaging and 3D 1H MR spectroscopic imaging--correlation with pathologic findings. Radiology. 2008 Feb;246(2):480-8.

Brader P*, Stritzker J, Riedl CC*, Zanzonico P, Cai S, Burnazi EM, Ghani ER , Hricak H, Szalay AA, Fong Y, Blasberg R. E. coli Nissle 1917 fascilates tumor detection by PET and optical imaging. Clinical Cancer Research, 2008 Apr;14(8):2295-302. 2008

Dobrenkov K, Olszewska M, Likar Y, Shenker L, Vider J, Gunset G, Hricak H, Sadelain M, Ponomarev V*. Monitoring the Efficacy of Adoptively Transferred Prostate Cancer-Targeted Human T-Lymphocytes Using PET and Bioluminescence Imaging. J Nuc Med, 2008 July;49(7): 1162-70

Akin O*, Sala E, Moskowitz CS, Ishill N, Soslow RA, Chi DS, Hricak H. Perihepatic Metastases from Ovarian Cancer: Sensitivity and Specificity of CT for the Detection of Metastases with and Those without Liver Parenchymal Invasion. Radiology 2008; Aug.; 248 (2):511-7. Radiology 2008; Aug.; 248 (2):511-7


Riedl CC*, Brader P*, Zanzonico PB, Chun YS, Woo Y, Singh P, Carlin S, Wen B, Ling CC, Hricak H, Fong Y.Imaging hypoxia in orthotopic rat liver tumors with iodine 124-labeled iodoazomycin galactopyranoside PET. Radiology. 2008 Aug;248(2):561-70.

Mitchell DG, Snyder B, Coakley F*, Reinhold C, Thomas G, Amendola MA, Schwartz LH, Woodward P, Pannu H, Atri M, Hricak H. Early invasive cervical cancer: MRi and CT predictors of lymphatic matastases in the ACRIN 6651/GOG 183 intergroup study. Gynecol Oncol. 2009 Jan;112(1):95-103.

Zhang J*, Kang S, Wang L*, Touijer AK, Hricak H. Distribution of Renal Tumor Growth Rates Determined with Serial Volumetric CT Measurements. Radiology. 2009 Jan;250(1):137-44

Riedl CC, Brader P, Zanzonico PB, Chun YS, Woo Y, Singh P, Carlin S, Wen B, Ling CC, Hricak H, Fong Y. Imaging hypoxia in orthotopic rat liver tumors with iodine 124-labeled iodoazomycin galactopyranoside PET. Radiology. 2008 Aug;248(2):561-70.

Paparel P, Akin O, Sandhu JS, Otero JR, Serio AM, Scardino PT, Hricak H, Guillonneau B. Recovery of Urinary Continence after Radical Prostatectomy: Association with Urethral Length and Urethral Fibrosis Measured by Preoperative and Postoperative Endorectal Magnetic Resonance Imaging. Eur Urol. 2008 Sep 2 [Epub ahead of print]

Mitchell DG, Snyder B, Coakley F, Reinhold C, Thomas G, Amendola MA, Schwartz LH, Woodward P, Pannu H, Atri M, Hricak H. Early invasive cervical cancer: MRI and CT predictors of lymphatic metastases in the ACRIN 6651/GOG 183 intergroup study. Gynecol Oncol. 2009 Jan;112(1):95-103

Likar Y, Dobrenkov K, Olszewska M, Shenker L, Cai S, Hricak H, Ponomarev V. PET imaging of HSV1-tk mutants with acquired specificity toward pyrimidine- and acycloguanosine-based radiotracers. Eur J Nucl Med Mol Imagin. 2009 Mar 4.

Brader P, Kelly K, Gang S, Shah JP, Wong RJ, Hricak H, Blasberg RG, Fong Y, Gil Z. Imaging of lymph node micrometastases using an oncolytic herpes virus and [F]FEAU PET. PLoS ONE. 2009;4(3):e4789.

Brame RS, Zaider M, Zakian KL, Koutcher JA, Shukla-Dave A, Reuter VE, Zelefsky MJ, Scardino PT, Hricak H. Regarding the Focal Treatment of Prostate Cancer: Inference of the Gleason Grade from Magnetic Resonance Spectroscopic Imaging. Int J Radiat Oncol Biol Phys. 2009 May 1;74(1):110-4

Brader P, Kelly KJ, Chen N, Yu YA, Zhang Q, Zanzonico P, Burnazi EM, Ghani RE, Serganova I, Hricak H, Szalay AA, Fong Y, Blasberg RG. Imaging a Genetically Engineered Oncolytic Vaccinia Virus (GLV-1h99) Using a Human Norepinephrine Transporter Reporter Gene. Clin Cancer Res. 2009 Jun 1;15(11):3791-801.

Shukla-Dave A, Hricak H, Ishill N, Moskowitz CS, Drobnjak M, Reuter VE, Zakian KL, Scardino PT, Cordon-Cardo C. Prediction of prostate cancer recurrence using magnetic resonance imaging and molecular profiles. Clin Cancer Res. 2009 Jun 1;15(11):3842-9.

Mazaheri Y, Hricak H, Fine S, Akin O, Shukla-Dave A, Ishill N, Moskowitz C, Grater J, Reuter V, Zakian K, Touijer K, and Koutcher J, Prostate Tumor Volume Measurement with Combined T2-weighted Imaging and Diffusion-weighted MR: Correlation with Pathologic Tumor Volume, Radiology 2009;252:449-4573